DRUG

Generated by OntoTerm. Updated: 03/09/2002 18:26:02

DRUG

Definition: medical substance used as a medicine to cure or get relief.

Conceptual Structures
ISA	THERAPEUTICAL-MATERIAL
SUBCLASSES	ANTIHISTAMINIC-DRUG ANTI-INFECTIVE-AGENT ANTINEOPLASTIC-AGENT BLOOD-FORMATION-COAGULATION-DERIVATIVES CARDIOVASCULAR-DRUG CENTRAL-NERVOUS-SYSTEM-AGENT GASTROINTESTINAL-DRUG HORMONES-AND-SYNTHETIC-SUBSTITUTES ILLEGAL-DRUG IMMUNOSUPPRESSIVE-AGENT LOCAL-ANESTHETIC RESPIRATORY-SYSTEM-DRUG SENSORY-ORGAN-DRUG TOPICAL-AGENT UROGENITAL-SYSTEM-DRUG VACCINE VITAMIN
DESCENDANTS	ACE ACETAMIDE ACIVICIN ACLACINOMYCIN ACOPP ACTINOMYCIN-D ACYCLOVIR ADOC ALANINE ALANOSINE ALKALOID ALKYLATING-DRUG ALPHA-INTERFERON ALTRETAMINE AMSACRINE ANALGESIC ANGUIDINE ANTHRAPYRAZOLE ANTI-HYPERTENSION-DRUG ANTI-INFECTIVE-AGENT ANTI-INFLAMMATORY-AGENT ANTIACID-AGENT ANTIANDROGEN ANTIBIOTIC ANTIDEPRESSANT ANTIDIARREHEA-AGENT ANTIEMETIC ANTIHISTAMINIC-DRUG ANTIMETABOLITE ANTINEOPLASTIC-AGENT ANTIPSYCHOTIC-TRANQUILIZER-AGENT ANTIPYRETIC ANTITUBERCULOSIS-AGENT ANTITUSSIVE-EXPECTORANT-AGENT ANTIVIRAL-AGENT ANXIOLYTIC-AND-SEDATIVE APHIDICOLIN-GLYCINATE ASPARAGINASE AZACYTIDINE AZATHIOPRINE BENZISOQUINOLINEDIONE BETACAROTENE BIOLOGICAL-RESPONSE-MODIFIER BIPHENQUINATE BISANTRENE-HYDROCHLORIDE BLEOMYCIN BLOOD-FORMATION-COAGULATION-DERIVATIVES BRUCEANTIN BUSULFAN CABO CAFFEINE CAP CARBOPLATIN CARDIOVASCULAR-DRUG CARMUSTINE CENTRAL-NERVOUS-SYSTEM-AGENT CETIRIZINE CHAD CHLORAMBUCIL CHLOROZOTOCIN CISCA CISPLATIN CLOMESONE COCAINE COLLYRIUM COMBINATION-ANTICANCER-AGENT CONTRACEPTIVE CYANOMORPHOLINO-ADR CYCLOCYTIDINE CYCLODISONE CYCLOPHOSPHAMIDE CYTARABINE CYTOSINE DACARBAZINE DAUNORUBICIN DECITABINE DEOXYDOXORUBICIN DEXAMETHASONE DIANHYDROGALACTITOL DIAZIQUONE DIBENZYLDAUNORUBICIN DICHLOROLAPACHOL DIGLYCOALDEHYDE DIHYDRO-5-AZACYTIDINE DIURETIC DOXORUBICIN EPIRUBICIN ESTRAMUSTINE ETHANESULFONIC-ACID ETOPOSIDE FAC FAM FLOXURIDINE FLUOROFUR FLUOROPAN FLUOROURACIL FLURACIL FLUTAMIDE GASTROINTESTINAL-DRUG GENERAL-ANESTHETIC GUANAZOLE GUANOSINE HEPSULFAM HEROIN HORMONAL-ANTICANCER-AGENT HORMONES-AND-SYNTHETIC-SUBSTITUTES HYDRAZINECARBOTHIOAMIDE HYDROXYUREA HYPOTENSIVE-AGENT IDARUBICIN IFOSFAMIDE ILLEGAL-DRUG IMIZADOLE-PYRAZOLE IMMUNOSUPPRESSIVE-AGENT INTERFERON INTERLEUKIN-2 IPROPLATIN L-ASPARAGINASE L-ASPARTIC-ACID LAXATIVE LEUCINE LEUKOVORIN LEUPROLIDE LEVAMISOLE LIDOCAINE LOCAL-ANESTHETIC LOMUSTINE M-2 M-BACOD MACBECIN MACC MAP-ANTICANCER MARIJUANA MAYSANINE MECHLORETAMINE MEDROXYPROGESTERONE MEGESTROL MELPHALAN MERCAPTOPURINE MESNA METHANESULFONATE METHOTREXATE METHOXSALEN METHYLNOGAROL METHYLPREDNISOLONE MITOMYCIN MITOTANE MITOTIC-INHIBITOR MITOXANTRONE MITOZOLOMIDE MORPHINE MORPHOLINO-ADR NARCOTIC NEOCARZINOSTATIN NICOTINE NITROGEN-MUSTARD NITROSUREA OPIATE-AGONIST ORAL-CONTRACEPTIVE OXANTHRAZOLE PACLITAXEL PALLIATIVE-DRUG PENTOSTATINE PHENACETIN PIPERAZINE-ALKYLATOR PIPERAZINEDIONE PIPOBROMAN PLATINATE PREDNISONE PROCAINE PROCARBAZINE PROMETHAZINE PROPANE PROPANOL PSYCHOTHERAPEUTIC-AGENT PYRAZOFURIN PYRAZOLOACRIDINE PYRIDINE-2-CARBOXALDEHYDE RADIOPROTECTOR RADIOSENSITIZER RAPAMYCIN RESPIRATORY-SYSTEM-DRUG RETINOIDS RHIZOXIN RUBIDAZONE SENSORY-ORGAN-DRUG SPIROHYDANTOIN-MUSTARD STEM-CELL-INHIBITOR STIMULANT TAMOXIFEN TENIPOSIDE TEROXIRONE TETRAPLATIN-PLATINUM THIADIAZOLE THIOGUANINE THIOGUANOSINE THIOTEPA THYMOSIN TOPICAL-AGENT TRETAMINE TRIMETREXATE UNCLASSIFIABLE-CHEMOTHERAPEUTIC-AGENTS URACIL-NITROGEN-MUSTARD UROGENITAL-SYSTEM-DRUG VACCINE VASODILATING-AGENT VINBLASTINE VINCRISTINE VINDESINE VITAMIN
ANCESTORS	ALL MATERIAL OBJECT PHARMACEUTICAL-MATERIAL PHYSICAL-OBJECT THERAPEUTICAL-MATERIAL
RELATIONS	HAS-ACRONYM : RYLIC-PAINT (by default) HAS-TRADENAME : TRADE-NAME (by default) INSTRUMENT-OF : CANCER-TREATMENT (by default) MEDICATE (by default) MERCHANDISE-OF : DRUGSTORE (by default) PRODUCT-TYPE-OF : HEALTH-CARE-ORGANIZATION LABORATORY-PHARMACEUTICAL (by default) USED-IN : CANCER-TREATMENT
ATTRIBUTES	TOXICITY : High TOXICITY : Medium TOXICITY : Low WAY-OF-ADMINISTRATION : injection WAY-OF-ADMINISTRATION : oral
INHERITED RELATIONS	CONTAINED-IN : PHYSICAL-OBJECT (from PHYSICAL-OBJECT ) MANUFACTURED-CONTAINER (by default) (from PHYSICAL-OBJECT ) ELEMENT-OF : COLLECTION (from OBJECT ) LOCATION : PLACE (from PHYSICAL-OBJECT ) MADE-OF : MATERIAL (from MATERIAL ) MATERIAL-OF : DRUG (by default) (from PHARMACEUTICAL-MATERIAL ) MEASURED-BY : MEASURING-ARTIFACT (from MATERIAL ) OBJECT-NAME : NAME (from PHYSICAL-OBJECT ) OWNED-BY : HUMAN (from PHYSICAL-OBJECT ) PART-OF : OBJECT (from OBJECT ) SUBSTRATE-OF : MOTION-EVENT (from MATERIAL ) THEME-OF : EVENT (from MATERIAL ) USED-IN-THE-TREATMENT-OF : DISEASE-EVENT (from PHARMACEUTICAL-MATERIAL ) HAVE-NEOPLASM (from PHARMACEUTICAL-MATERIAL )
INHERITED ATTRIBUTES	AGE : >0 (from MATERIAL ) COLOR : MAGENTA (from MATERIAL ) CYAN (from MATERIAL ) RED (from MATERIAL ) ORANGE (from MATERIAL ) NAVY-BLUE (from MATERIAL ) TAN (from MATERIAL ) YELLOW (from MATERIAL ) GREEN (from MATERIAL ) GRAY (from MATERIAL ) BLUE (from MATERIAL ) PURPLE (from MATERIAL ) SIZE : <=0>=1000000 (from PHYSICAL-OBJECT ) STATE-OF-MATTER : LIQUID (from PHARMACEUTICAL-MATERIAL ) SOLID (from PHARMACEUTICAL-MATERIAL )